Please provide your email address to receive an email when new articles are posted on . Initiation of biological therapy within 12 months was associated with a higher rate of transmural healing ...
ANDOVER, Mass., November 22, 2025--(BUSINESS WIRE)--Transmural Systems, a leader in pioneering electrosurgical structural heart therapies, obtained 510(k) clearance from the United States Food and ...
Please provide your email address to receive an email when new articles are posted on . Endologix announced that the FDA has granted approval of its percutaneous transmural arterial bypass system for ...
In patients with Crohn’s disease (CD) who were in endoscopic remission, achieving intestinal ultrasound (IUS) transmural healing was associated with decreased risks for CD relapse, hospitalization, ...
Endologix LLC reported 12-month results from the second of two studies of a fully percutaneous, transmural arterial bypass therapy for treating peripheral arterial disease. Presented at this month's ...
In patients with ulcerative colitis who had endoscopic healing, achieving transmural healing was associated with longer relapse-free survival. Women and those who had received multiple advanced ...
PLASMA and serum enzyme-activity alterations have proved useful as laboratory parameters in the diagnosis of myocardial disease. 1 Among the enzymes employed to reflect myocardial necrosis are ...
Transmural Systems, a leader in pioneering electrosurgical structural heart therapies, obtained 510(k) clearance from the United States Food and Drug Administration (FDA) for TELLTALE – the first and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results